ViroPharma Discontinues Maribavir Phase 3 Study in Liver ... - RTT News PDF Print

The company said its decision was made based on the results of the phase 3 study of maribavir in stem cell transplant patients, and the recommendation from ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.